Shengxiang Biotech announced that some of the company's shares held by Chen Wenyi, the original shareholder holding 5% or more of the company's shares, will be judicially enforced. The court will allow the applicant to sell 5.71 million shares of Shengxiang Biotech shares in batches through bulk transactions or centralized bidding in the secondary market. The holdings reduction period is no later than December 30, 2027. After enforcement, Chen Wenyi's shareholding will drop from 26.427,400 shares to 207.17,400 shares, and the shareholding ratio will drop from 4.56% to 3.58%. This matter does not affect the stability of the company's control and daily operations.

Shengxiang Biotech announced that some of the company's shares held by Chen Wenyi, the original shareholder holding 5% or more of the company's shares, will be judicially enforced. The court will allow the applicant to sell 5.71 million shares of Shengxiang Biotech shares in batches through bulk transactions or centralized bidding in the secondary market. The holdings reduction period is no later than December 30, 2027. After enforcement, Chen Wenyi's shareholding will drop from 26.427,400 shares to 207.17,400 shares, and the shareholding ratio will drop from 4.56% to 3.58%. This matter does not affect the stability of the company's control and daily operations.